China Meheco Group Co., Ltd. is a pharmaceutical company based in China with an ESG risk rating score of 40.5, indicating severe risk. The company is involved in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. China Meheco Group Co., Ltd. offers a wide range of botanic medicines, herbal products, and natural medicines for export. Their business operations span the entire industry chain, including research and development, cultivation, processing, manufacturing, distribution, logistics, and international trading. They also provide trading services for pharmaceutical and chemical customers, covering APIs, preparations, biologicals, blood products, and more.